{"url":"https://lda.senate.gov/api/v1/filings/bb2f19c5-9d0b-4bfb-a3e1-ac8d181afddb/","filing_uuid":"bb2f19c5-9d0b-4bfb-a3e1-ac8d181afddb","filing_type":"RR","filing_type_display":"Registration","filing_year":2023,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/bb2f19c5-9d0b-4bfb-a3e1-ac8d181afddb/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Minor, Partner","dt_posted":"2023-08-30T11:56:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"500 8th Street, NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":76855,"url":"https://lda.senate.gov/api/v1/registrants/76855/","house_registrant_id":32113,"name":"DLA PIPER LLP (US)","description":"Law firm.","address_1":"500 8th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM MINOR","contact_telephone":"+1 202-799-4312","dt_updated":"2026-07-30T08:35:35.415773-04:00"},"client":{"id":56944,"url":"https://lda.senate.gov/api/v1/clients/56944/","client_id":56944,"name":"CURRAX PHARMACEUTICALS LLC","general_description":"Specialty pharmaceutical business","client_government_entity":null,"client_self_select":false,"state":"TN","state_display":"Tennessee","country":"US","country_display":"United States of America","ppb_state":"TN","ppb_state_display":"Tennessee","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-05-03"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Legislative and regulatory policies and proposals related to obesity treatment, including the Treat and Reduce Obesity Act of 2023.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":139476,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"GREENWOOD","suffix":null,"suffix_display":null},"covered_position":"U.S. Representative","new":true},{"lobbyist":{"id":101694,"prefix":null,"prefix_display":null,"first_name":"ALEX","nickname":null,"middle_name":null,"last_name":"PINSON","suffix":null,"suffix_display":null},"covered_position":"Schedule C appointee, Dept. of Health and Human Services; Senior Legis. Asst. and Counsel (and other positions), Rep. Hal Rogers; Intern, Rep. Cory Gardner; Intern, Rep. Trey Gowdy","new":true},{"lobbyist":{"id":139175,"prefix":"mr","prefix_display":"MR.","first_name":"JAMIE","nickname":null,"middle_name":"ALEXEI","last_name":"GREGORIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}